Kelly Ranallo is a healthcare business entrepreneur, long-term parent advocate and the Founder/President of the Turner Syndrome Global Alliance (TSGA).
Angie Dunbar has been involved with RareKC since the beginning, serving as Board Chair for the past two years.
Alli Kafka is the Program Director for RareKC. She is responsible for the overall management and implementation of RareKC programs according to strategic objectives set by the Board of Directors.
Dennis Ridenour became President and Chief Executive Officer of BioNexus KC on February 18th, 2019.
Dr. Kimminau is a biomedical anthropologist and health services researcher who has worked throughout her career with organizations trying to meet the health needs of their communities.
Amber Heinemann joined RareKC in 2018 and currently functions as the co-chair of the fundraising and development committee.
Jay L. Vivian PhD is a Research Associate Professor and Scientific Director of the Transgenic and Gene Targeting Facility at the University of Kansas Medical Center, and the Director of the Rare Disease Research Center at the Children’s Research Institute of Children’s Mercy Kansas City.
Dr. Eric Rush is a Clinical Geneticist at Children’s Mercy Hospital and the University of Kansas Medical Center. He is an Associate Professor of Pediatrics at the University of Missouri-Kansas City.
Mindy Bridges is an assistant professor at the University of Kansas Medical Center. Broadly, her research interests include the connection between language and reading development and disorders.